Inactive Instrument

Highlights OWC Pharmaceutical Research Corp. Other OTC

Equities

OWCP

US67109N1081

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

OWC Pharmaceutical Research Corp. Announces New Distribution Agreement with Can It Industries	20-09-14	CI
Owc Pharmaceutical Research Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-13	CI
Stenocare A/S and Owc Pharmaceutical Research Corp. Enters into Partnership to Develop Advanced Medical Cannabis Products	19-11-13	CI
Owc Pharmaceutical Research Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-13	CI
OWC Pharmaceuticals Research Receives Permit for Cannabis Based Ointment Efficacy Trial	19-08-05	CI
OWC Pharmaceuticals Research Corp. Receives Approval from Israeli Medical Cannabis Agency	19-07-24	CI
Owc Pharmaceutical Research Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-15	CI
OWC Pharmaceutical Research Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-01	CI
OWC Pharmaceutical Research Corp. to Collaborate with Sourasky Medical Center in Tel Aviv for a Safety Study on its Cannabis-Based Tablets	19-03-27	CI
OWC Pharmaceutical Research Corp. Reports Positive Phase 1 Safety Data for its Medical Grade Cannabis MSG Ointment for the Treatment of Skin Diseases	19-01-29	CI
OWC Pharmaceutical Research Corp. Reports the Successful Production of Cannabinoid-Enriched Sublingual Disintegrating Tablet	18-12-18	CI
OWC Pharmaceutical Research Corp. to Report Progress in Clinical Trials for Ointment Care for Skin Diseases	18-11-29	CI
OWC Pharmaceutical Research Corp Successfully Tests Unique, Innovative Delivery Formulation Aimed At Multiple Myeloma Therapy	18-10-22	CI
OWC Pharmaceutical Research Corp. Initiated Final Stage of Cannabinoid-Based Topical Ointment Safety Study	18-08-01	CI
OWC Pharmaceutical Research Corp Completes Development of Next Generation Orally-Disintegrating Tablet	18-06-13	CI
OWC Pharmaceutical Research Corp. Announces Update on its Proprietary Medical Cannabis Sublingual Tablet	17-12-20	CI
OWC Pharmaceutical Research Corp Releases Promising Preliminary Results from Efficacy Tests of its Topical Cream	17-03-20	CI
OWC Pharmaceutical Research Corp. Receives IRB Approval to Initiate Safety Testing on Cannabinoid-Infused Cream for Treatment of Psoriasis	17-02-27	CI
OWC Pharmaceutical Research Corp Completes Development of its Medical Cannabis Sublingual Tablet	16-10-20	CI
OWC Pharmaceutical Research Corp Signs Agreement with Medmar LLC	16-09-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights OWC Pharmaceutical Research Corp. Other OTC

Equities

OWCP

US67109N1081

Highlights

Filters